Axsome Therapeutics, Inc. AXSM 深 沪
交易中 05-11 10:54:39 美东时间
215.96
-1.415
-0.65%
华盛通- 最 高227.45
- 今 开216.08
- 成交量 11.59万股
- 最 低 213.455
- 昨 收 217.375
- 总市值 840.38万
- 52周最高 234.29
- 市盈率 静 --
- 换手率 297.88%
- 52周最低 96.09
- 委 比 -13.73%
- 总股本 3.89万
- 历史最高 234.29
- 量 比 0.51
- 振 幅 6.44%
- 历史最低 1.10
- 每 手 1
- 风险率 30.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock
Axsome (AXSM) Q1: Revenue beats, but wider loss and rising expenses weigh on shares. Get the key data on Sunosi and Auvelity sales.
05-04 20:18
Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipeline amid bullish analyst targets.
04-02 01:36
Earnings Scheduled For February 23, 2026
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
William Blair upgrades Neumora after strong Alzheimer's agitation data, sees upside from NMRA-511 and obesity pipeline potential.
02-18 03:32
FDA Fast-Tracks Axsome's Alzheimer's Agitation Drug, Stock Soars
The FDA accepted Axsome Therapeutics Inc.'s supplemental NDA for AXS-05 for Alzheimer's agitation with a Priority Review date.
2025-12-31 23:30
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Uncovering Potential: Axsome Therapeutics's Earnings Preview
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings ...
2025-11-01 02:01
广发证券：焦炭第二和第三轮提涨连续落地 后续供应收缩预期加强支撑煤价上行
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 广发证券发布研报称，近期，各煤种价格普涨，焦炭第二和第三轮提涨连续落地。当前煤炭...
2025-08-05 16:27
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
Axsome Therapeutics joins Alzheimer’s advocacy efforts to highlight rising impact of Alzheimer’s disease in the U.S., with 7.2 million currently affected and projected to rise to 14 million by 2060. The company emphasizes brain health awareness and provides resources to support those affected.
2025-06-20 11:00
